Results 231 to 240 of about 191,374 (287)

Dual-target VIM-PSA deep brain stimulation using octopolar electrodes: surgical technique and feasibility study. [PDF]

Front Neurol
Triguero-Cueva L, Martínez-Barbero JP, Madrid-Navarro CJ, Pérez-Navarro MJ, Mínguez-Castellanos A, Marín-Romero B, Iáñez-Velasco B, Escamilla-Sevilla F, Katati MJ.   +8 more
europepmc   +1 more source

Artificial Voices, Real Causes: The Dilemma of Virtual Influencer‐Driven Brand Activism

Psychology &Marketing, EarlyView.
ABSTRACT Brands are more frequently adopting virtual influencers (VIs) to lead activism campaigns. However, little is known about when and how such activism effectively drives consumer engagement. This research, in Study 1, examines 14,464 Instagram posts from 18 diverse VIs using large‐scale analytics to assess engagement intensity and the dynamics of
Sampa Anupurba Pahi, Debasis Pradhan, Abhisek Kuanr, Baidyanath Biswas, Jingyu Zhu   +4 more
wiley   +1 more source

Early detection and localization of recurrent prostate cancer using [Formula: see text]F-DCFPyL PET/CT in patients with low and ultra-low PSA levels. [PDF]

EJNMMI Res
Sonni I, Gulpe A, Nickols NG, Schaffer D, Montagut L, Berenji GR, Rettig MB.   +6 more
europepmc   +1 more source

Implementation and First Results of the Czech Nationwide Prostate Cancer Screening Pilot Program. [PDF]

Eur Urol Open Sci
Koudelková M, Hejcmanová K, Babjuk M, Zachoval R, Ferda J, Bratt O, Chloupková R, Ngo O, Hejduk K, Válek V, Dušek L, Májek O.   +11 more
europepmc   +1 more source

Use of androgen suppression therapy at salvage radiotherapy in recurrent prostate cancer: a systematic review with meta-analysis. [PDF]

Front Urol
Chaves Medina MJ, Varela Ramírez R, Donoso Donoso W, Moreno-Chaparro J, Eslava-Schmalbach J.   +4 more
europepmc   +1 more source

Potential influence of long non-coding RNA <i>NEAT1</i> genetic variants and expression levels on the progression of prostate cancer. [PDF]

J Cancer
Mei CE, Lin CY, Wang SS, Su SC, Wu HH, Chang LC, Tang CH, Yang SF.   +7 more
europepmc   +1 more source

Relationship between prostate-specific antigen and prostate volume in benign enlargement of the prostate: a descriptive cross-sectional study. [PDF]

Ann Med Surg (Lond)
Kc S, Lamichhane S, Devkota S, Maharjan S, Chaudhary S, Kafle A, Karkee RJ, Gupta RK.   +7 more
europepmc   +1 more source

Computational identification and experimental validation of shared diagnostic biomarkers and gene signatures across HLA-B27-associated immune-mediated diseases. [PDF]

J Transl Med
Zhu X, Liang C, Xu Z, Zhao X, Shi L, He J, Liu K, Zhou P, Xie K, Jin B, Zhu H, Du L, Li L.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

SERUM-PSA, F/T PSA, PSAD, PSA-TZ AND PSA VELOCITY

The Journal of Urology, 1999
The clinical value of prostate-specific antigen (PSA) density in differentiating between prostate cancer and benign prostatic hyperplasia has been the subject of several studies. In this context the question has been raised about the diagnostic benefit of PSA transition-zone density (PSA-TZ density = total PSA/transition-zone volume) in the detection ...
Bob Djavan, Mesut Remzi, Christian Seitz, Michael Marberger, Alex Zlotta, Peter Hammerer   +5 more
openaire   +3 more sources